Sana Biotechnology, Inc.
NASDAQ:SANA
Overview | Financials
Company Name | Sana Biotechnology, Inc. |
Symbol | SANA |
Currency | USD |
Price | 1.7 |
Market Cap | 379,557,300 |
Dividend Yield | 0% |
52-week-range | 1.55 - 12 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Steven D. Harr M.D. |
Website | https://www.sana.com |
An error occurred while fetching data.
About Sana Biotechnology, Inc.
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD